Block Listing Interim Review

Name of applicant:

ALLERGY THERAPEUTICS PLC

Name of scheme:

Allergy Therapeutics plc 2013 Long Term Incentive Plan 

Period of return:

From:

1 October 2023

To:

 17 December 2024

Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:

10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017

Additional listing of 7,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 7 April 2021

Additional listing of 5,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 3 October 2023

Balance of unallotted securities under scheme(s) from previous return:

12,013,147 ordinary shares

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Less:  Number of securities issued/allotted under scheme(s) during period:

12,013,147 ordinary shares of 0.1p each

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

Nil

Name of contact:

Karley Cheesman

Telephone number of contact:

+44 (0) 1903 844 700